Comments to FDA: Considering Whether an FDA-Regulated Product Involves the Application of Nanotechnology Share page: Docket Number: FDA-2010-D-0530 CHPA applauds the approach for creating a public forum to collect current research and comments to advance the science of engineered nanomaterials. Download Document Issues: OTC Medicines Sunscreen Other Issues Quality Related Posts Press Releases and Statements West Virginia Expands Access to OTC Cold & Allergy Medications Containing PSE Mar 6, 2024 Press Releases and Statements CHPA Statement on Valisure Citizen Petition Mar 6, 2024 Summary of State Sales Tax Jun 1, 2018